The Healthy and At-Risk Populations Program currently has 26 members, 12 of whom are new to the cancer center. The new members include a number of senior and junior recruits to UCLA, as well as previously unaffiliated UCLA faculty members. A new senior level recruit is Lenore Arab, Ph.D., whose focus is on nutrition and cancer. The JCCC provided critical support for Dr. Arab's research. In addition, we were fortunate that the School of Nursing recently recruited Felicia Hodge, Dr.PH, who is also Director, Center for American Indian/Indigenous Research and Education (CAIRE) on the UCLA campus. Dr. Hodge has a long history of tobacco control and cancer screening research in native American populations and has been an excellent addition to HARP. Also in the past funding cycle, Robert Kaplan, Ph.D., was recruited to be the Chair of Health Services in the School of Public Health, and he has joined HARP. Dr. Kaplan is an internationally renowned scholar in the areas of health services and health psychology and conducts research in broad content areas including tobacco control, cancer screening, quality of life, and quality of care. Other internal senior level faculty who have been attracted to join HARP during the past funding cycle include Lillian Gelberg, M.D., Family Medicine and Leeka Kheifets, Ph.D., Epidemiology. Junior faculty recruited to UCLA during the past cycle who have newly joined the cancer center include Michael Ong, M.D., Ph.D., General Internal Medicine-Health Services and Dominic Frosch, Ph.D., General Internal Medicine-Health Services Research. The Program is extremely dynamic, and is viewed as a welcoming and supportive environment for collaborative research. Our members have national and international reputations, and we have in our program three members of the Institute of Medicine. The total number of publications in the last cycle was 425 out of which 18% were inter-programmatic and 18% were intra-programmatic indicating a high level of collaborative research in the program. Fourteen percent of the publications could be characterized as high impact. During the current funding year, peerreviewed funding totaled $11.4 million in total costs, including $5.3 million from the National Cancer Institute. As with other Program Areas, JCCC fosters a number of interactive activities and many of the Shared Resources that support investigators in the HARP Program Area. During the current grant cycle, funds from the JCCC in the form of CCSG Developmental Funds, institutional support and philanthropic gifts to the HARP Program Area total $348,500. These funds supported Seed Grants, the annual Helene Brown award and trainees. Four of the Program Area Members were the recipients of JCCC support.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016042-38
Application #
8392128
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
38
Fiscal Year
2013
Total Cost
$142,225
Indirect Cost
$66,161
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Waters, Lynnea R; Ahsan, Fasih M; Wolf, Dane M et al. (2018) Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience 5:99-109
Van Dyk, Kathleen; Bower, Julienne E; Crespi, Catherine M et al. (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25
Robinett, Ryan A; Guan, Ning; Lux, Anja et al. (2018) Dissecting Fc?R Regulation through a Multivalent Binding Model. Cell Syst 7:41-48.e5
Chin, Chee Jia; Li, Suwen; Corselli, Mirko et al. (2018) Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells. Stem Cell Reports 10:436-446
Alban, Tyler J; Alvarado, Alvaro G; Sorensen, Mia D et al. (2018) Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. JCI Insight 3:
Yang, Qing; Fung, Wing K; Li, Gang (2018) Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks. Stat Med 37:1389-1401
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987
Ribas, Antoni; Wolchok, Jedd D (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350-1355
Wang, Hong; Chen, Xiaolin; Li, Gang (2018) Survival Forests with R-Squared Splitting Rules. J Comput Biol 25:388-395

Showing the most recent 10 out of 767 publications